TFAP2A and obstructive sleep apnea syndrome: Here, we screened 13 ferroptosis-related genes as treatment targets for CPAP-treated OSA, and the ROC of combined DRD5 and TFAP2A was 0.988, which had the diagnostic value for OSA.